enVVeno Medical Announces the Development of a Transcatheter Based Replacement Venous Valve for the Treatment of Chronic Venous Insufficiency

~ Potential relief to approximately 3.5 million CVI sufferers ~ Designed to be used by an expansive network of physicians ~ Initial bench testing and animal testing successfully completed ~ Awaiting regulatory approval to begin first-in-human testing, which is expected by end of 2022 ~ Company to host conference call with live audio webcast today, Wednesday, September 21st at 4:30 PM ET

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.


Please enter your comment!
Please enter your name here